Manchester Medical Society

Events & Meetings

Become a member

Immunological aspects of transplantation

  • Date: Thursday 18th November 2021 from 1.00-2.00 pm
  • Venue: Zoom
  • Members £0.00
  • Non Members £

This meeting is being subsidised by the Manchester Medical Society and is FREE for all to attend. You will be able to submit questions to the speaker during the event using the Q&A function on Zoom.

Register in advance for this webinar at:

After registering, you will receive a confirmation email containing information about joining the webinar.  To create a free zoom account, visit

1.00-2.00 pm

Epidemiology of renal transplantation : a 20 year single centre analysis
Professor Philip Kalra, Professor of Nephrology, Director of Research and Innovation: NCA, Salford Royal NHS FT

Synopsis of lecture:

Professor Kalra will describe a retrospective cohort study of all renal transplant patients followed up at Salford Royal Hospital over 20 years from 2000 to 2020.  961 patients were identified through the transplant database. Transplants before 2000 were excluded. Data on patient demographics, comorbidities, malignancy, clinical variables and medication history were collected. Outcome data to be presented will include patient death, progression of GFR, graft loss, cardiovascular events, malignancy and new-onset diabetes after transplant (NODAT).

Learning objectives:

  1. Current renal transplant survival has increased significantly and median is around 16 years
  2. Low incidence of graft loss (9%) and malignancy (8.7%) during an average follow up of over 7 years
  3. Commonest transplant-specific viral infections were CMV (13%) and EBV (10%)

“Immunological issues in renal transplantation”
Dr Anirudh Rao, Consultant Nephrologist, Royal Liverpool University Hospital

Synopsis of lecture:

This talk aims to cover the basic concepts and key components of transplant immunology as well as practicalities of work up and managing renal transplant recipient, including living donor organ exchange schemes, virtual crossmatching, HLA and ABO incompatible transplantation.